Mesenchymal stem cells: Therapeutic outlook for stroke

Trends in Molecular Medicine

Volumn 18, Issue 5, 2012, Pages 292-297

  Honmou, Osamu ^a,b,c   Onodera, Rie ^a   Sasaki, Masanori ^a,b,c   Waxman, Stephen G ^b,c   Kocsis, Jeffery D ^b,c  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ANGIOPOIETIN 1; BRAIN DERIVED NEUROTROPHIC FACTOR; ENDOGLIN; NEUROTROPHIN; VASCULOTROPIN;

ANGIOGENESIS; BONE MARROW CELL; BRAIN CELL; BRAIN EDEMA; BRAIN ISCHEMIA; CELL CULTURE; CELL LINEAGE; CELL SURVIVAL; DIFFUSION WEIGHTED IMAGING; DISEASE MODEL; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL DIFFERENTIATION; NERVE REGENERATION; NERVE SPROUTING; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 1 CLINICAL TRIAL (TOPIC); REMYELINIZATION; REVIEW; SPINAL CORD INJURY; STROKE; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; STROKE; TISSUE THERAPY;

ANIMALIA;

EID: 84860539878     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2012.02.003     Document Type: Review

References (51)

1. Cramer S.C., et al. Activation of distinct motor cortex regions during ipsilateral and contralateral finger movements. J. Neurophysiol. 1999, 81:383-387.
2. Jiang Q., et al. Magnetization transfer MRI: application to treatment of middle cerebral artery occlusion in rat. J. Magn. Reson. Imaging 2001, 13:178-184.
3. Chopp M., et al. Neurogenesis, angiogenesis, and MRI indices of functional recovery from stroke. Stroke 2007, 38:827-831.
4. Caplan A.I. Mesenchymal stem cells. J. Orthop. Res. 1991, 9:641-650.
5. Caplan A.I., Correa D. The MSC: an injury drugstore. Cell Stem Cell 2011, 9:11-15.
6. Caplan A.I. Review: mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Eng. 2005, 11:1198-1211.
7. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997, 276:71-74.
8. Pittenger M.F., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
9. Sanchez-Ramos J., et al. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp. Neurol. 2000, 164:247-256.
10. Kobune M., et al. Telomerized human multipotent mesenchymal cells can differentiate into hematopoietic and cobblestone area-supporting cells. Exp. Hematol. 2003, 31:715-722.
11. Azizi S.A., et al. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats -similarities to astrocyte grafts. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:3908-3913.
12. Brazelton T.R., et al. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 2000, 290:1775-1779.
13. Woodbury D., et al. Adult rat and human bone marrow stromal cells differentiate into neurons. J. Neurosci. Res. 2000, 61:364-370.
14. Kim S., et al. Neural differentiation potential of peripheral blood- and bone-marrow-derived precursor cells. Brain Res. 2006, 1123:27-33.
15. Massengale M., et al. Hematopoietic cells maintain hematopoietic fates upon entering the brain. J. Exp. Med. 2005, 201:1579-1589.
16. Bianco P., et al. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2008, 2:313-319.
17. Honma T., et al. Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Exp. Neurol. 2006, 199:56-66.
18. Chen J., et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001, 32:1005-1011.
19. Li Y., et al. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 2002, 59:514-523.
20. Horita Y., et al. Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat. J. Neurosci. Res. 2006, 84:1495-1504.
21. Iihoshi S., et al. A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats. Brain Res. 2004, 1007:1-9.
22. Nomura T., et al. I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Neuroscience 2005, 136:161-169.
23. Liu H., et al. Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia. Brain 2006, 129:2734-2745.
24. Shen L.H., et al. One-year follow-up after bone marrow stromal cell treatment in middle-aged female rats with stroke. Stroke 2007, 38:2150-2156.
25. Chen X., et al. Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology 2002, 22:275-279.
26. Chen J., et al. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J. Neurosci. Res. 2003, 73:778-786.
27. Kurozumi K., et al. BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Mol. Ther. 2004, 9:189-197.
28. Sasaki M., et al. BDNF-hypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury. J. Neurosci. 2009, 29:14932-14941.
29. Toyama K., et al. Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia. Exp. Neurol. 2009, 216:47-55.
30. Onda T., et al. Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia. J. Cereb. Blood Flow Metab. 2008, 28:329-340.
31. Zhang Z., Chopp M. Vascular endothelial growth factor and angiopoietins in focal cerebral ischemia. Trends Cardiovasc. Med. 2002, 12:62-66.
32. Carmeliet P., Collen D. Molecular analysis of blood vessel formation and disease. Am. J. Physiol. 1997, 273:H2091-H2104.
33. Bates D.O., et al. Regulation of microvascular permeability by vascular endothelial growth factors. J. Anat. 2002, 200:581-597.
34. Sasaki M., et al. Focal experimental autoimmune encephalomyelitis in the Lewis rat induced by immunization with myelin oligodendrocyte glycoprotein and intraspinal injection of vascular endothelial growth factor. Glia 2010, 58:1523-1531.
35. Suri C.M.J., et al. Increased vascularization in mice overexpressing angiopoietin-1. Science 1998, 282:468-471.
36. Yancopoulos G.D., et al. Vascular-specific growth factors and blood vessel formation. Nature 2000, 407:242-248.
37. Ward N.L., Lamanna J.C. The neurovascular unit and its growth factors: coordinated response in the vascular and nervous systems. Neurol. Res. 2004, 26:870-883.
38. Thurston G., et al. Leakage-resistant bloods in mice transgenically overexpressing angiopoietin-1. Science 1999, 286:2511-2514.
39. Sundberg C., et al. Stable expression of angiopoietin-1 and other markers by cultured pericytes: phenotypic similarities to a subpopulation of cells in maturing vessels during later stages of angiogenesis in vivo. Lab. Invest. 2002, 82:387-401.
40. Baffert F., et al. Angiopoietin-1 decreases plasma leakage by reducing number and size of endothelial gaps in venules. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:H107-H118.
41. Carmeliet P. Blood vessels and nerves: common signals, pathways and diseases. Nat. Rev. Genet. 2003, 4:710-720.
42. Dore-Duffy P., et al. Pericyte migration from the vascular wall in response to traumatic brain injury. Microvasc. Res. 2000, 60:55-69.
43. Miki Y., et al. Vascular endothelial growth factor gene-transferred bone marrow stromal cells engineered with a herpes simplex virus type 1 vector can improve neurological deficits and reduced infarction volume in rat brain ischemia. Neurosurgery 2007, 61:586-594. discussion 594-595.
44. Crisan M., et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008, 3:301-313.
45. Alvarez-Buylla A., Lim D.A. For the long run: maintaining germinal niches in the adult brain. Neuron 2004, 41:683-686.
46. Luskin M.B., et al. Neuronal progenitor cells derived from the anterior subventricular zone of the neonatal rat forebrain continue to proliferate in vitro and express a neuronal phenotype. Mol. Cell. Neurosci. 1997, 8:351-366.
47. Bang O.Y., et al. Autologous mesenchymal stem cell transplantation in stroke patients. Ann. Neurol. 2005, 57:874-882.
48. Lee J.S., et al. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 2010, 28:1099-1106.
49. Honmou O., et al. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain 2011, 134:1790-1807.
50. Sasaki M., et al. Development of a middle cerebral artery occlusion model in the nonhuman primate and a safety study of I.V. infusion of human mesenchymal stem cells. PLoS ONE 2011, 6:e26577.
51. Majumdar M.K., et al. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J. Cell. Physiol. 1998, 176:57-66.